Table 3.
Distribution of viral parameters among patients with and without insulin resistance
| Total (n = 146) | Insulin resistance | p | ||
|---|---|---|---|---|
| Positive (n = 77) | Negative (n = 69) | |||
| HBsAg, median (IQR) | 4044 (1094-4794) | 3917 (555-5018) | 4113 (2065-4730) | 0.829 |
| Anti-HBs, median (IQR) | 1.22 (0.28-3.49) | 1.42 (0.38-3.93) | 1.02 (0.24-2.83) | 0.441 |
| HBeAg, median (IQR) | 0.33 (0.29-0.37) | 0.33 (0.29-0.37) | 0.33 (0.30-0.37) | 0.808 |
| Anti-HBe, median (IQR) | 0.01 (0.01-0.02) | 0.01 (0.01-0.02) | 0.01 (0.01-0.02) | 0.380 |
| Anti-HDV, positivity, n (%) | 3 (2.1) | 1 (1.3) | 2 (2.9) | 0.603# |
| HBV-DNA, median (IQR) | 366 (43-1400) | 410 (42-1950) | 350 (46-1200) | 0.537 |
#
, Fisher's exact test; n, number of patients; %, percentage of column: IQR, interquartile range (25–75%); HBsAg, hepatitis B surface antigen; Ani-HBs, anticore against HBsAg; HBeAg: hepatitis Be antigen; anti-HBe, anticore against HBeAg; HDV, hepatitis D virus; HBV, hepatitis B virus; DNA, deoxyribonucleic acid